Fibrin film, an elastic sheet prepared from a fibrin clot, was first described in 1944.' The precursor is a fibrin clot of the type designated as "coarse," whose fiber structure consists of thick bundles of protofibrils formed in the natural blood coagulation process, containing 5 to 10 mg/mL of fibrin protein, the remainder being buffer solution. This is gently compacted in one dimension with syneresis of buffer solution to reduce the thickness by a factor of the order of 20 while the area remains essentially ~n c h a n g e d .~,~ The natural structure is preserved except that its fibrous elements lie primarily in the plane of the film, though oriented at random within that plane. This fibrin film can be stretched 100% with subsequent elastic recovery after release of tension. It has been used in surgical applications4 and has been the subject of several recent investigations to elucidate fibrin s t r u c t~r e .~-~ The width of the fibers comprising the fibrin clot structure can be decreased by increasing the pH and ionic strength at which clotting by thrombin takes place, culminating in the "fine" clot in which the fibrous elements consist of single protofibrilss or segments of two or three twisted t~g e t h e r .~ Such a clot does not synerize and cannot be compacted under pressure. However, it has now been found possible to remove the buffer by osmosis to compact a fine clot in one dimension and prepare a fine fibrin film that has similar elastic properties. Moreover, the same method can be applied to other fragile protein gels such as gelatin and denatured serum albumin. The resulting protein films may have various practical applications.
MATERIALS AND METHODSBovine fibrinogen (Miles Laboratories, 95% clottable) was dissolved in and dialyzed against a large volume of sodium chloride-imidazole buffer, pH 8.5, ionic strength 0.41. A solution containing 10 g/L of fibrinogen with 2 units/mL of Trasylol (proteolytic inhibitor, from FBA pharmaceuticals) and 0.003M calcium chloride (to introduce y-y covalent bonds by ligation-sufficient fibrin stabilizing factor, Factor XIII, being present as a desired Biotechnology and Bioengineering, Vol. XXVI, Pp. 191-193 (1984) impurity) was mixed with sufficient thrombin (bovine, from Parke, Davis, and Company) to give a specified clotting time, usually about 10 min, and poured into a 2 X 5 in. polyethylene tray. The resulting transparent clot was allowed to stand at room temperature, covered by a lid, for at least 16 h to allow the structure to become fully developed. 5,9 A sample of pigskin gelatin was generously provided by Rousselot S . A. (Paris; France); it had been used in other investigations in this laboratory.lO.il Its isoelectric point was 7.0, the pH of an aqueous solution was 5.1, and the number-average molecular weight was 3.5 X lo4. It was dissolved in water at 50°C at a concentration of 6% by weight. The solution was kept in the covered polyethylene tray for 15 h at 7OoC to erase any aggregation history, then cooled to room temperature and held for 5 h.Bov...